Virtus Lifesci Biotech Etf Probability of Future Etf Price Finishing Under 22.55

BBC Etf  USD 26.85  0.73  2.79%   
Virtus LifeSci's future price is the expected price of Virtus LifeSci instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Virtus LifeSci Biotech performance during a given time horizon utilizing its historical volatility. Check out Virtus LifeSci Backtesting, Portfolio Optimization, Virtus LifeSci Correlation, Virtus LifeSci Hype Analysis, Virtus LifeSci Volatility, Virtus LifeSci History as well as Virtus LifeSci Performance.
  
Please specify Virtus LifeSci's target price for which you would like Virtus LifeSci odds to be computed.

Virtus LifeSci Target Price Odds to finish below 22.55

The tendency of Virtus Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 22.55  or more in 90 days
 26.85 90 days 22.55 
near 1
Based on a normal probability distribution, the odds of Virtus LifeSci to drop to $ 22.55  or more in 90 days from now is near 1 (This Virtus LifeSci Biotech probability density function shows the probability of Virtus Etf to fall within a particular range of prices over 90 days) . Probability of Virtus LifeSci Biotech price to stay between $ 22.55  and its current price of $26.85 at the end of the 90-day period is about 9.66 .
Considering the 90-day investment horizon the etf has the beta coefficient of 1.66 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Virtus LifeSci will likely underperform. Additionally Virtus LifeSci Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Virtus LifeSci Price Density   
       Price  

Predictive Modules for Virtus LifeSci

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Virtus LifeSci Biotech. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
24.1626.1228.08
Details
Intrinsic
Valuation
LowRealHigh
24.8126.7728.73
Details
Naive
Forecast
LowNextHigh
22.3024.2626.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
25.5128.7732.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Virtus LifeSci. Your research has to be compared to or analyzed against Virtus LifeSci's peers to derive any actionable benefits. When done correctly, Virtus LifeSci's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Virtus LifeSci Biotech.

Virtus LifeSci Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Virtus LifeSci is not an exception. The market had few large corrections towards the Virtus LifeSci's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Virtus LifeSci Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Virtus LifeSci within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.26
β
Beta against Dow Jones1.66
σ
Overall volatility
1.23
Ir
Information ratio -0.1

Virtus LifeSci Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Virtus LifeSci for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Virtus LifeSci Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Virtus LifeSci generated a negative expected return over the last 90 days
Virtus LifeSci Biotech generated five year return of -2.0%
This fund holds 98.9% of its assets under management (AUM) in equities

Virtus LifeSci Technical Analysis

Virtus LifeSci's future price can be derived by breaking down and analyzing its technical indicators over time. Virtus Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Virtus LifeSci Biotech. In general, you should focus on analyzing Virtus Etf price patterns and their correlations with different microeconomic environments and drivers.

Virtus LifeSci Predictive Forecast Models

Virtus LifeSci's time-series forecasting models is one of many Virtus LifeSci's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Virtus LifeSci's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.

Things to note about Virtus LifeSci Biotech

Checking the ongoing alerts about Virtus LifeSci for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Virtus LifeSci Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Virtus LifeSci generated a negative expected return over the last 90 days
Virtus LifeSci Biotech generated five year return of -2.0%
This fund holds 98.9% of its assets under management (AUM) in equities
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Virtus LifeSci Backtesting, Portfolio Optimization, Virtus LifeSci Correlation, Virtus LifeSci Hype Analysis, Virtus LifeSci Volatility, Virtus LifeSci History as well as Virtus LifeSci Performance.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.